Hyatt Regency Princeton Pharmaceutical Group Sales Manager earns Prestigious Healthcare Meeting Compliance Certification
/
Date13 Feb 2017
PRINC_P053_Private_Dining_Room_69645_small Princeton Exterior PRINCETON, N.J., Feb. 13, 2017 (GLOBE NEWSWIRE) — The Hyatt Regency Princeton announced today that their Pharmaceutical Group Sales Manager, Saundra Conte... Read More →
Senior Secured Lender Agrees to Extend Maturity of Gevo’s 2017 Notes from March 15, 2017 to June 23, 2017
/
Date13 Feb 2017
ENGLEWOOD, Colo., Feb. 13, 2017 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ:GEVO), announced today that WB Gevo, Ltd. (“Whitebox”), the holder of the Company’s issued and... Read More →
Noble Energy Provides Detailed 2017 Outlook and Guidance
/
Date13 Feb 2017
Full-year sales volumes have been raised to 415 – 425 MBoe/d, up nearly 5 percent from last year, after adjusting for 2016 divestment impacts. Volumes... Read More →
Envision Healthcare Sets Earnings Release and Conference Call Dates for Fourth-Quarter and Full-Year 2016 Results
/
Date13 Feb 2017
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo., Feb. 13, 2017 (GLOBE NEWSWIRE) — Envision Healthcare Corporation (NYSE: EVHC) today announced it will release its fourth-quarter and... Read More →
Relypsa Announces Publication of Results of Veltassa Drug-Drug Interaction Studies in Journal of Cardiovascular Pharmacology and Therapeutics
/
Date13 Feb 2017
Phase 1 studies with 12 oral medications commonly used in hyperkalemic patients with chronic kidney disease showed minimal risk for drug-drug interactions with Veltassa when... Read More →
Tyson Foods, Inc. Announces Quarterly Dividend
/
Date13 Feb 2017
SPRINGDALE, Ark., Feb. 13, 2017 (GLOBE NEWSWIRE) — The Board of Directors of Tyson Foods, Inc. (NYSE:TSN), at a meeting on February 8, 2017, declared... Read More →
Quantenna Announces Fourth Quarter and Fiscal 2016 Financial Results
/
Date13 Feb 2017
FREMONT, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) — Quantenna Communications, Inc. (NASDAQ:QTNA), a global leader and innovator of leading-edge performance Wi-Fi solutions, today announced preliminary... Read More →
Aviragen Therapeutics Announces Top-Line Results from Phase 2b SPIRITUS Trial of Vapendavir
/
Date13 Feb 2017
ATLANTA, Feb. 13, 2017 (GLOBE NEWSWIRE) — Aviragen Therapeutics (NASDAQ:AVIR), a company focused on the discovery and development of the next generation of direct-acting antivirals... Read More →
Shurtape Technologies, LLC, Expands Tape Business with Acquisition of Syntac Coated Products, LLC
/
Date13 Feb 2017
Hickory, N.C., Feb. 13, 2017 (GLOBE NEWSWIRE) — Shurtape Technologies, LLC, an industry-leading producer of pressure-sensitive tapes, announces the acquisition of Syntac Coated Products, LLC,... Read More →
Is Gilead Sciences Getting Ready for a Massive Acquisition?
/
Date13 Feb 2017
Gilead Sciences (NASDAQ: GILD) reported enough bad news on Tuesday to inspire a blues song: Falling revenue. Sinking earnings. Horrible outlook for this year. Perhaps... Read More →